Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J. Casterella

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Heart Journal|April 29, 2008
Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisionsPeter J Casterella, James E Tcheng
Current Treatment Options in Cardiovascular Medicine|March 10, 2001
Restenosis after AngioplastyMehran Moussavian, Peter J. Casterella, Paul S. Teirstein
The Journal of Invasive Cardiology|March 5, 2008
Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventionPeter J Casterella, James R Revenaugh, James L Burke, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) studyRoxana Mehran, Eugenia Nikolsky, Ajay J Kirtane, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 21, 2015
One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) StudyGennaro Giustino, Usman Baber, Ioannis Mastoris, et al.
Journal of the American College of Cardiology|February 7, 2003
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin StudyDeepak L Bhatt, Benjamin I Lee, Peter J Casterella, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Heart Journal|April 29, 2008
Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisionsPeter J Casterella, James E Tcheng
Current Treatment Options in Cardiovascular Medicine|March 10, 2001
Restenosis after AngioplastyMehran Moussavian, Peter J. Casterella, Paul S. Teirstein
The Journal of Invasive Cardiology|March 5, 2008
Real-world safety and efficacy of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventionPeter J Casterella, James R Revenaugh, James L Burke, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) studyRoxana Mehran, Eugenia Nikolsky, Ajay J Kirtane, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 21, 2015
One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) StudyGennaro Giustino, Usman Baber, Ioannis Mastoris, et al.
Journal of the American College of Cardiology|February 7, 2003
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin StudyDeepak L Bhatt, Benjamin I Lee, Peter J Casterella, et al.
Pageof 1